YOLFTbeta
Noul Co. Ltd.

Noul Co. Ltd.

376930 · KQ · Healthcare / Diagnostics & Research

1,930.00KRW-215.00 (-10.02%)

Price History

Full chart

Market Stats

Previous Close2,145.00
Open2,230.00
Day Range1,912.00 – 2,255.00
52-Week Range1,335.00 – 15,925.00
Volume1.02M
Market Cap14.57B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.48
50-Day Avg2,044.22
200-Day Avg5,815.51

About

Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Chan-Yang Lim
  • Employees104
  • Headquarters338, Gwanggyojungang-ro, Yongin-si, South Korea, 16942, Korea
  • Websitehttps://www.noul.kr

Leadership

  • Mr. Chan-Yang LimCo-Founder & CEO
  • Attorney Bahn-Suk KimCo-Founder & Chief Production Officer · b. 1949
  • Mr. Young Shin Ph.D.Co-Founder & AI Lab Expert
  • Mr. Justin AhnChief Operating Officer
  • Mr. Simon Y. ShinDirector of Sales & Marketing Division
  • Ms. Michelle JeongHead of Global Business Development & Sales Circle
  • Mr. Samuel M. Song Ph.D.Head of Prep Circle
  • Mr. Howard HamHead of AI Circle
  • Mr. Louis SongHead of PDM Circle
  • Ms. Kelly KimHead of Finance Management Circle

Financials

Income Statement

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0295.26M1.48B541.88M2.73B1.60B5.12B
Growth (%)--+399.66%-63.27%+404.51%-41.42%+219.83%
Cost of Revenue0207.41M1.09B536.41M2.65B2.48B4.70B
Gross Profit087.85M380.93M5.47M85.13M-879.30M419.14M
Gross Margin-29.75%25.82%1.01%3.11%-54.91%8.18%
Operating Expense4.77B7.35B11.82B15.64B16.22B21.92B20.50B
Operating Income-4.77B-7.27B-11.44B-15.63B-16.14B-22.79B-20.08B
Operating Margin--2460.81%-775.29%-2884.82%-590.33%-1423.37%-392.03%
EBITDA----11.57B-13.98B-20.06B-17.28B
EBITDA Margin----2135.50%-511.41%-1252.90%-337.35%
Net Income-5.99B-8.97B-12.31B-13.68B-16.32B-22.47B-19.95B
Net Income Margin--3039.09%-834.61%-2524.55%-597.00%-1403.05%-389.60%
R&D-4.13B5.78B7.38B6.97B9.24B5.10B
R&D as % of Total Revenue-1398.93%391.90%1362.44%254.94%576.66%99.49%
Interest Expense0925.48M765.30M392.34M468.89M415.59M499.45M
Interest Expense % of Total Revenue-313.44%51.87%72.40%17.15%25.95%9.75%

Balance Sheet

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.79B15.56B19.96B25.85B55.58B37.81B39.22B
Total Liabilities7.37B28.21B18.10B14.46B12.59B17.64B13.54B
Total Equity-4.58B-12.64B1.86B11.40B42.99B20.17B25.68B
Cash1.21B97.59M194.81M2.04B6.61B250.58M656.29M
Net Debt-1.10B1.01B2.30B-5.69B4.54B

Cash Flow

Currency: KRW2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.01B-6.83B-10.55B-14.51B-15.25B-20.11B-20.53B
Investing Cash Flow-614.58M-11.52B-2.10B-1.04B-24.83B10.54B-
Financing Cash Flow5.75B17.24B12.74B17.40B44.66B3.20B-
Capital Expenditure335.59M3.04B507.64M2.29B236.66M265.36M2.88B
Free Cash Flow--9.87B-11.09B-16.81B-15.49B-20.37B-23.41B
FCF to OCF-144.52%105.07%115.79%101.55%101.32%114.03%

Earnings

Report DateMar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------
EPS Actual-298.46-706.45-712.52-655.64-641.93-635.76-902.96-538.79-491.58-967.10-532.47-824.92-541.95-666.08-498.90-617.58-454.09-457.31
Surprise------------------
Timing------------------

Key Statistics & Ratios

Market Cap14.57B
Enterprise Value9.34B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.98
Price / Book0.97
Revenue (TTM)3.66B
Gross Profit (TTM)600.32M
EBITDA-17.75B
Profit Margin0.00%
Operating Margin-476.16%
Return on Equity-145.40%
Return on Assets-46.03%
Shares Outstanding10.26M
Shares Float9.13M
Beta-0.48
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 7, 20261:5
  • Sep 25, 20232:1